JP2008510812A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510812A5
JP2008510812A5 JP2007530013A JP2007530013A JP2008510812A5 JP 2008510812 A5 JP2008510812 A5 JP 2008510812A5 JP 2007530013 A JP2007530013 A JP 2007530013A JP 2007530013 A JP2007530013 A JP 2007530013A JP 2008510812 A5 JP2008510812 A5 JP 2008510812A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally
alkoxy
heterocycle
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007530013A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510812A (ja
JP5038139B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/029806 external-priority patent/WO2006026235A1/en
Publication of JP2008510812A publication Critical patent/JP2008510812A/ja
Publication of JP2008510812A5 publication Critical patent/JP2008510812A5/ja
Application granted granted Critical
Publication of JP5038139B2 publication Critical patent/JP5038139B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007530013A 2004-08-25 2005-08-23 サイトカインインヒビター Expired - Lifetime JP5038139B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60425404P 2004-08-25 2004-08-25
US60/604,254 2004-08-25
PCT/US2005/029806 WO2006026235A1 (en) 2004-08-25 2005-08-23 Cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2008510812A JP2008510812A (ja) 2008-04-10
JP2008510812A5 true JP2008510812A5 (https=) 2008-10-09
JP5038139B2 JP5038139B2 (ja) 2012-10-03

Family

ID=35355697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530013A Expired - Lifetime JP5038139B2 (ja) 2004-08-25 2005-08-23 サイトカインインヒビター

Country Status (8)

Country Link
US (1) US7470692B2 (https=)
EP (1) EP1786801B1 (https=)
JP (1) JP5038139B2 (https=)
AT (1) ATE460410T1 (https=)
CA (1) CA2577446C (https=)
DE (1) DE602005019893D1 (https=)
ES (1) ES2339364T3 (https=)
WO (1) WO2006026235A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0911681B8 (pt) * 2008-04-23 2021-05-25 Rigel Pharmaceuticals Inc composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro
AU2009289378A1 (en) 2008-09-02 2010-03-11 Boehringer Ingelheim International Gmbh Novel benzamides, production thereof, and use thereof as medicaments
ATE547402T1 (de) * 2008-09-02 2012-03-15 Boehringer Ingelheim Int 7-(piperazin-1-ylmethyl)-1h-indol-2-carbonsäure (phenyl) -amidderivate und verwandte verbindungen als p38 map-kinase-inhibitoren zur behandlung von atemwegserkrankungen
EP2722329A1 (en) * 2012-10-18 2014-04-23 F. Hoffmann-La Roche AG Indol-amide compounds as beta-amyloid inhbitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE469142T1 (de) * 2002-04-11 2010-06-15 Boehringer Ingelheim Pharma Heterocyclische amid-derivate als cytokin- inhibitoren
US7078419B2 (en) 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors

Similar Documents

Publication Publication Date Title
JP2007536231A5 (https=)
AU2019416589B2 (en) Heterocyclic compound intermediate, preparation method therefor and application thereof
JP7792915B2 (ja) Cd38阻害薬
CA2903288C (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
ES2566772T3 (es) Inhibidores de la quinasa c-fms
ES2197167T3 (es) Imidazoles trisustituidos con multiples propiedades terapeuticas.
ES2327940T3 (es) 3-(4-heterociclil-1,2,3-triazol-1-il)-n-aril-benzamidas en calidad de inhibidores de la produccion de citocinas para el tratamiento de enfermedades inflamatorias cronicas.
ES2601226T3 (es) Derivados de imidazol como inhibidores de IDO
US12421196B2 (en) Inhibitors of NLRP3 inflammasome
HRP20161010T1 (hr) C5ar antagonisti
RS56388B1 (sr) Supstituisana jedinjenja benzaldehida i postupci za njihovu upotrebu u povećanju oksigenacije tkiva
AU2017330618A1 (en) TRPV4 antagonists
WO2001053267A1 (en) Compounds exhibiting thrombopoietin receptor agonism
KR20030008151A (ko) 이미다조피리딘 및 이미다조피리미딘 항바이러스제
CA2662196A1 (en) Inhibitors of phosphatidylinositol 3-kinase
WO2004106293A2 (en) Oxazolyl - and thiazolyl - purine based tricyclic compounds.
JPWO2009041447A1 (ja) 5員複素環化合物
JP2007513167A5 (https=)
JP2007537255A5 (https=)
JP7012289B2 (ja) ベンゾイルグリシン誘導体およびその作製および使用の方法
ES2325318T3 (es) Derivados de triazol como inhibidores de la ciclooxigenasa (cox).
JP2008509955A5 (https=)
JP2006514940A5 (https=)
EP4469460A1 (en) N-oxide inhibitors of nlrp3 inflammasome
JP2011518168A (ja) ホスファチジルイノシトール3−キナーゼの阻害薬